Advanced Oncotherapy PLC and Spire Healthcare announce a collaboration to offer patients a new type of cancer treatment at Spire Healthcare hospitals in the UK
Spire Healthcare Ltd and Advanced Oncotherapy Plc today announced that they have signed a letter of intent to bring more affordable proton radiotherapy to the UK. This agreement will enable Spire to further expand, and complement, its existing range of oncology services.
Advanced Oncotherapy Plc is a British company whose patented technology makes proton beam therapy for cancer treatment more affordable. Their state of the art proton beam machine is based on LIGHT technology – Linac Image Guided Hadron Technology – a direct medical application of high energy particle physics research by ADAM at CERN (The Large Hadron Collider).
Proton radiotherapy is at the forefront of the fight against cancer, but the UK lags behind its US and European counterparts, despite the government having recently announced funding for two NHS proton radiotherapy centres in London and Manchester. Protons are established as being a much more accurate form of treatment than conventional radiotherapy, causing far fewer side effects. However, previously, machines have been prohibitively expensive.
With the new LIGHT machine at Spire hospitals, costs will be substantially cheaper, and patients benefit from easy access, convenient locations, and the ability to treat cancers more precisely. This represents a game-changing new treatment option for cancer patients in the UK, and underpins the commitment of both companies to high quality, affordable and innovative care.
Advanced Oncotherapy’s CEO, Dr Mike Sinclair, said, “We have long been sure that this technology has the potential to bring the benefits of proton beam therapy to many more cancer patients than is possible currently. Our belief has been endorsed by one of the private sector’s largest and most forward thinking hospital groups. We are delighted to partner with Spire Healthcare for these new exciting centres”.
Rob Roger, Spire Healthcare’s Chief Executive, added, “We are delighted to be working with Advanced Oncotherapy on the development of a new delivery system for proton beam therapy. This reinforces our position as a provider of affordable high quality cancer care throughout our network of hospitals”.